FDA Inspection 1018192 — Pablo E. Pergola, M.D., Ph.D.
The FDA completed an inspection of Pablo E. Pergola, M.D., Ph.D. on June 23, 2017 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 23, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional Details
Clinical Investigator (CI)